Benlysta is a human monoclonal antibody that was approved for the treatment of lupus in adults by the U.S. Food and Drug Administration (FDA) in 2011 and for lupus nephritis in adults in 2020.

Benlysta (belimumab) is a biologic developed by Human Genome Sciences in partnership with GlaxoSmithKline (GSK). A biologic is a large, complex molecule that is produced using recombinant DNA ...

If you can become pregnant, it’s important to consider whether Benlysta is a safe choice for you. Monoclonal antibodies, such as belimumab (the active drug in Benlysta), may affect the immune system ...

Benlysta starts working right away, but it may take time for you to see improvements in your symptoms. Some people started to see improvements after 8 weeks. Benlysta starts working right away after ...

Please provide your email address to receive an email when new articles are posted on . In the 10 years since its first FDA approval for systemic lupus erythematosus in 2011, belimumab has altered the ...

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Benlysta (belimumab) - Drug Insight and Market Forecast - 2030 ...

WASHINGTON (CBSNewYork.com/AP) The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in over 50 years, a milestone that medical ...

The Food and Drug Administration has approved Human Genome Sciences' Benlysta to treat lupus. This medicine is an impressive collection of firsts: not only is it the first drug approved to treat lupus ...

Benlysta (belimumab) is a prescription drug that’s used to help manage certain types of lupus. It’s not known whether Benlysta is safe to use while pregnant or breastfeeding. If you can become ...